Search the Blog

Ready to Elevate Your Wellness?

Discover the power of premium supplements designed for relief, relaxation, recovery, and more. Experience the difference today!

cbd and diabetes featured

CBD and Diabetes: A Look at What Research Actually Shows

Share Post, Share Love

Table of Contents

Important: This article is for educational purposes only and is not medical advice. Diabetes is a serious chronic disease that should be managed by a primary-care provider, endocrinologist, or diabetes care team. CBD is not approved by the FDA to treat diabetes. Never replace prescribed insulin or oral diabetes medications with a supplement.

Diabetes — both Type 1 and Type 2 — is one of the most-asked-about conditions in cannabinoid research. Because cannabinoid receptors are expressed in metabolic tissue, there has been interest in whether cannabinoid signaling intersects with glucose regulation. The honest answer is that the evidence remains preliminary, that some studies have shown the opposite of what wellness blogs suggest, and that nothing about consumer CBD replaces standard diabetes care.

The short version

  • CBD is not a treatment for diabetes. No CBD product is FDA-approved for Type 1 diabetes, Type 2 diabetes, prediabetes, or any diabetes complication.
  • A widely-cited 2016 small clinical trial of CBD in Type 2 diabetes (Jadoon et al.) did not show improvement in glycemic control, lipid profiles, or insulin sensitivity at the doses tested.
  • Standard diabetes care includes glycemic monitoring, prescribed medications (insulin for Type 1; metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, and others for Type 2), nutrition, and physical activity. These have decades of evidence behind them.

What diabetes actually is, briefly

Diabetes is a group of metabolic conditions characterized by elevated blood glucose:

  • Type 1 diabetes is an autoimmune condition in which the pancreas no longer produces insulin. Lifelong insulin therapy is essential.
  • Type 2 diabetes involves insulin resistance and progressive beta-cell dysfunction. Treatment is highly individualized and now includes a wide menu of medications, lifestyle interventions, and in selected patients metabolic surgery.
  • Gestational diabetes develops during pregnancy and resolves after delivery in most cases.

Tight glycemic control reduces the risk of complications including retinopathy, nephropathy, neuropathy, and cardiovascular disease.

What CBD-and-diabetes research has actually shown

The most-cited clinical work is Jadoon et al. (2016), a randomized, placebo-controlled trial that examined CBD and the related cannabinoid THCV in 62 patients with non-insulin-treated Type 2 diabetes:

  • The CBD arm did not show a statistically significant improvement in glycemic control, fasting glucose, HbA1c, or insulin sensitivity compared to placebo.
  • THCV showed some metabolic effects in this study, but THCV is a different cannabinoid than CBD and is not what most consumer “CBD” products contain.
  • The trial was small and short, and the results have not been replicated in larger studies.

Beyond Jadoon, the published evidence is mostly preclinical (animal models examining effects on islet cells, inflammation, and metabolic pathways). This is hypothesis-generating work; it does not establish that consumer CBD products improve outcomes in human diabetes.

Why this matters for blood sugar safety

Two specific concerns:

  • Hypoglycemia interactions. Patients on insulin or insulin-secretagogues (sulfonylureas, glinides) need predictable medication effects. Adding any supplement that could interact with drug metabolism creates uncertainty in blood-glucose response.
  • Substituting CBD for prescribed therapy is dangerous. This is especially true for Type 1 diabetes, where insulin is non-negotiable. Any patient who stops insulin in favor of a supplement is at risk of diabetic ketoacidosis, which is life-threatening.

Drug-interaction considerations

CBD is metabolized through liver enzymes (CYP3A4 and CYP2C19) that also process several medications used in diabetes-related care: certain statins, some antihypertensives, and a number of medications used for diabetic neuropathy and depression that often coexist with diabetes. Discuss any supplement use with the prescribing clinician.

What the FDA has said

The FDA has not approved any CBD product for diabetes, prediabetes, or any diabetes-related condition. The agency has issued warning letters to companies marketing CBD as a treatment for diabetes; such claims make the product an unapproved new drug under federal law.

Talking to your endocrinologist or primary-care provider

If you live with diabetes and are curious about CBD, an honest conversation with the treating clinician is the right path. Useful questions:

  • Are any of my current medications metabolized through pathways CBD also affects?
  • If I do try a CBD product, should I monitor my blood sugar more closely for a period?
  • Are there any clinical trials in this area I should know about?
  • What are my current targets, and is my regimen optimized?

What we offer at New Phase Blends

We make third-party-tested CBD products designed for general wellness use. They are not formulated, tested, or marketed as treatments for diabetes or any metabolic disease. If you have diabetes, please continue to follow the plan your diabetes care team has built for you.

Frequently asked questions

Does CBD lower blood sugar? The strongest randomized data we have did not show CBD improving glycemic control in Type 2 diabetes. Marketing CBD as a blood-sugar treatment is not supported by the evidence and is an FDA enforcement target.

Can I stop my diabetes medication if I take CBD? No. Stopping prescribed diabetes medication, especially insulin in Type 1 diabetes, can be life-threatening.

Can CBD interact with metformin or insulin? Pharmacokinetic interactions with metformin and insulin are not well characterized in clinical studies, but CBD does affect liver enzyme activity broadly. If you are on multiple medications, ask the prescribing clinician.

What is the difference between CBD and THCV? Both are cannabinoids, but they have different pharmacology. Some preliminary research has examined THCV in metabolic contexts; this does not transfer to consumer CBD products.


Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease, including diabetes. The information here is for educational purposes only and is not a substitute for advice from a licensed medical professional.

Share Post, Share Love

Dale Hewett

Author

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for natural supplements use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same products that he himself uses to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD and other supplements to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

Scroll to Top